Post COVID 19 Long Hauler Risk of Diabetes Type One or Two Diagnosis, Management & Therapeutics Physician and Patient Handbook

By Dr. Frank Hamo PhD Biomedical Engineering

"The world has not been the same after the Covid–19 pandemic. The virus brought social and cultural change and became the root cause of resetting global operations and basic human functioning.

The prolonged symptoms of Covid–19 include fatigue, headaches, flu, and chronic pain in vital organs. Moreover, many people have reportedly been diagnosed with Post Covid–19 diabetes type 1 or type 2 related to pancreatic injury under the Covid infection.

Dr. Frank's book Post Covid–19 long–hauler risk of diabetes type 1 or type 2 provides detailed procedural methods deployed to tackle the spread of the progression of disease and monitor the stages and progress of its treatment.

Dr. Frank aims to assist physicians and caretakers in examining the severity of injury to the pancreas and derive a standard action plan to salvage healthy cells that will stop the progression of the disease from damaging the remaining healthy BETA cells.

The book contains multiple sections covering medications, food management, exercise, and an overview of a proposed design powered mobile application to collect and store screening data.

Dr. Frank Hamo is a Ph.D. degree holder in biomedical engineering and strives to put his vast knowledge to enhance the efficiency of healthcare institutions. By bringing in the resources of biomedical technology, Dr. Frank's vision remains to improve the dynamics of the overall treatment."

For more information visit: https://covid19complication.com/

• Language: English
• Publisher: Fulton Books, Inc.
• Release date: Jan 6, 2023
• ISBN: 9798885051491

Book preview

Title Page

Copyright © 2022 Dr. Frank Hamo PhD Biomedical Engineering

All rights reserved

First Edition

Fulton Books

Meadville, PA

Published by Fulton Books 2022

ISBN 979-8-88505-148-4 (paperback)

ISBN 979-8-88505-149-1 (digital)

Printed in the United States of America

CONTENTS

Section 1: Book Executive Summary

Section 2: Digestive System Structures and Functional Description

2.1 Pancreas Function

2.2 Pancreas Without Insulin

2.3 Liver Digestion

2.4 Digestive System Organs Involved

2.4.1 Process of Digestion Organs and Their Functions:

2.4.2 Liver

2.4.3 Gall bladder

2.4.4 Pancreas

2.4.5 Pancreatic Enzymes

2.5 Hormones Secretion

2.5.1 Pancreatic Hormones

Section 3: Detailed Evaluation of Islet Distribution in Pancreas

3.1 Pancreas Islet Distribution

3.2 Pancreas Islet and Beta Cell Distribution Evaluation by CT Scan

Section 4: COVID-19 Human Cells Entry Points

4.0 COVID-19 Entry into Host Cell

4.1 Three Ways Virus Host Cell Entries

4.2 ACE2 Expression

Section 5: Scientific Discussion Following COVID-19 Invades the Pancreatic Cells and Risk of Developing Diabetes

5.0 SARS-CoV-2 higher fasting plasma glucose levels

5.1 Real Data of COVID-19 and Pancreatic Injury

5.2 COVID-19 Infection with Past History of Pancreatitis

5.3 Pancreatic Endocrine System and COVID-19

5.4 What Causes Diabetes?

5.5 How Could COVID-19 Bring Out Type 1 Diabetes?

5.6 Conclusion

Section 6: Diabetes Related COVID Infection Screening and Management Starting by Completing Patients Survey

6.0 Managing Diabetes in Patients after COVID Infection

6.1 Type 2 Diabetes Symptoms Includes:

6.2 Type 1 Diabetes Symptoms Includes:

6.3 Confirm COVID PCR Test Positive or Negative

6.4 Conducting A1C Test

6.5 Conduct Amylase and Lipase Tests

6.6 Differentiate Between COVID-19 Symptoms or Pancreatitis May Include:

6.7 What Causes Abnormal Amylase Levels?

6.8 MRI Scan Evaluation of Pancreas Infection as COVID-Related

Section 7: Post COVID-19 Diabetes Food Management

7.0 Diet, Exercise, and Weight Loss

7.1 Food to Eat and Food